Arise, go forth, and solve structures
In 1962 -when Max Perutz and John Kendrew shared the Nobel prize for their work on protein crystal structures -who would have predicted that today there would be nearly 9,000 structures in a freely and easily accessible electronic database, and that scientists would be in a position to determine the structures of a representative set of all proteins? In those days, nucleic acid sequencing, which has now provided us with several complete genome sequences, had not been invented, computer technology for information analysis and transfer was still in its infancy, and structural biology was very difficult. Now, thanks to advances in methods for NMR spectroscopy, X-ray crystallography and data analysis, high resolution structures are churning out at a fast rate. The next big challenges for structural biologists lie in continuing to improve structural determination methods for difficult projects, such as experiments with membrane proteins; in determining high resolution structures of large complexes, such as the ribosome and spliceosome; in analyzing the dynamics of molecules; and in defining the finite set of all protein folds. This last challenge -known as structural genomics -stands to redefine the scope of structural biology. Although there are thousands of structures in the PDB, they represent only a few hundred fold topologies (out of an estimated 1,000-3,000), Therefore, scientists are seriously considering embarking on experimental projects to determine the structures of ~10,000 proteins, each of which would be expected to have a novel fold, based on lack of sequence homology to proteins with known structures. It is expected that such an effort will cover sequence space sufficiently and will allow scientists to use the techniques of homology modeling to assign all proteins with undetermined structures to defined fold families, based on sequence data alone. Such information would be of obvious use to anyone seeking to determine and modulate the function of a particular protein.
Several pilot projects, to determine procedures and scaling feasibility, have already begun. At a recent meeting in Avalon, New Jersey, reviewed by Andrej S ali (Rockefeller University) on page 1029 of this issue of Nature Structural Biology, ~200 scientists discussed many of the practicalities of such an effort. How will protein targets be chosen? What experimental procedures for collecting structural data are fastest, cheapest and most reliable? How will data from such a project be collected and analyzed? S ali's review is an excellent summary of the opinions and results aired at this meeting. It suggests that these projects will alter the research landscape of structural biology, although how soon changes will be widely noticeable is a matter of debate.
The effects of a large scale structural genomics project will be numerous. The cost per structure will decline, as methods become easier, faster and cheaper. Additionally, one or more large scale structural genomics centers (for both NMR spectroscopy and X-ray crystallography) may be established to maximize throughput of the selected targets. The large volume of structural data generated will have to be analyzed and integrated with results from other efforts, such as the human genome sequencing project, and this consolidation will probably december 1998 vol. 5 no. 12
For a set of links related structural genomics, visit the web specials section of the Nature Structural Biology homepage http://structbio.nature.com molecular form & function require increased computational power. Acceptance of results for publication, and also success in funding competitions, will likely depend on demonstration of functional and biological insight, even more so than they do today. Finally, as a result, structural biologists will become more well rounded in their approaches to the function of a protein, and similarly, molecular biologists will be more likely to use the results offered by structural work, as they become available for interesting proteins.
Currently, several pilot projects on different organisms are underway around the world (see S ali's meeting review). These projects will be useful for determining the amount of time and money that will be necessary for solving at least 10,000 structures. Enormous cooperation will be required to develop the structural genomics initiative into a large scale, federally funded project. Presumably, once a decision to launch a large scale project has been made, the disparate groups will have to agree on the targets -or at least how to divide up the set of potential targets -and how to proceed. Will a model organism (perhaps one from each of the three kingdoms) be chosen for study? Will the complete set of all available sequences be considered instead, with priority going to proteins that are thought to be interesting based on relation to disease or some other functional analysis of the gene product? These questions will require much thought; bias toward particular targets may imply that knowledge of which proteins are important is complete at this time, which is almost certainly not the case. Given the high degree of communication that exists at this early stage of development, through semi-annual meetings such as the one reviewed in this issue, discussion of these issues and subsequent cooperation seem easily achievable.
In fact, it is hoped by many that communication between the members of the project groups will extend beyond meetings and brainstorming sessions. Responding to a need to consolidate information on structural genomics efforts, a web database called PRESAGE (protein resource entailing structural annotation of genomic entities; http://presage.stanford.edu) has been established by Steven Brenner and colleagues at Stanford University and was mentioned at the meeting in Avalon. Progress on structural determinations and protein modeling studies may be deposited into this database. It will hopefully fill with prepublication information, such as lists of the targets that have been chosen by the different groups. Most organizers of the pilot programs believe that this database will foster cooperation as well as prevent duplication of effort on the same predicted proteins. This free exchange of information is in keeping with recent pushes in structural biology to distribute information more rapidly (such as by reducing the structural coordinate on hold time in the Protein Data Bank) and should be useful -if the data are deposited and annotated regularly by members of the community.
Nevertheless, structural biology is competitive, as are most scientific fields, and it is not likely that everyone in the structural genomics field will contribute prepublication results so readily, especially if their targets are disease related and are likely to be chosen to investigate an interesting functional question as much as to discover a novel fold. There are issues to consider, beyond fostering communication and preventing duplication of effort. For example, who might use the data to benefit his/her own research program or for-profit company, at the expense of the depositor as well as the overall structural genomics initiative? Related issues of competition are likely to arise throughout the course of the structural genomics effort and will have to be considered, but are not expected to hinder progress towards establishing a coordinated effort.
A large scale structural genomics project would irrefutably seem to offer great rewards. However, some people believe that structural genomics will be a somewhat empty promise: they think that protein functions will, as a rule, be too difficult to determine from folds alone. To that, proponents of structural genomics are likely to have many responses, not the least of which is that it seems presumptuous to assume that the future will not hold great advances in facilitating the understanding of protein function, in which structural data will play a key role. Some also worry that the excitement of academic science will be diminished by high throughput structural determination projects. However, current research in many genome-based fields opposes that view. For example, in C. elegans research, the genome sequencing project has allowed scientists to clone genes and examine their functions much more quickly and easily. There is no shortage of challenging and exciting problems in C. elegans biology just because the sequences are already known. So it will be with structural biology. Interesting and difficult problems will always exist -the bar will just be shifted up a notch. After completion of a large scale structural genomics project, there will be greater opportunity for all biologists to investigate functional interactions and pathways -to understand the details of the functions defined by the folds. 
